Atlanta Consulting Group Advisors »

Vertex Pharmaceuticals Incorporated shares owned by Atlanta Consulting Group Advisors

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Atlanta Consulting Group Advisors from 13F filings

Historical chart of Atlanta Consulting Group Advisors investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Atlanta Consulting Group Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Atlanta Consulting Group Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $201k 405 496.73
2024-09-30 $823k 1.8k 465.08
2024-06-30 $205k 438 468.72

More positions owned by Atlanta Consulting Group Advisors

Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p Mcp Etf (IJH)
Alliance Resource Partners L Ut Ltd Part (ARLP)
Ishares Core Msci Emkt (IEMG)
2023 Etf Series Trust Eagl Cap Sel Etf (EAGL)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
JPMorgan Chase & Co. (JPM)
Exxon Mobil Corporation (XOM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
First Tr Exchange-traded Wcm Intl Equity (WCMI)
Microsoft Corporation (MSFT)
Procter & Gamble Company (PG)

View all positions for Atlanta Consulting Group Advisors

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
BlackRock
Capital Research Global Investors
Vanguard Capital Management
State Street Corporation
Invesco
Jpmorgan Chase & Co
Geode Capital Management
Vanguard Portfolio Management
Capital Research and Management Company - Division 3
Loomis, Sayles and
Franklin Resources
Wellington Management Company
Morgan Stanley
Ubs Global Asset Management Americas

View all funds holding Vertex Pharmaceuticals Incorporated